000 nab a22 7a 4500
999 _c17466
_d17466
003 PC17466
005 20230519134615.0
008 230519b xxu||||| |||| 00| 0 eng d
040 _cH12O
041 _aspa, eng
100 _9891
_aVanaclocha Sebastián, Francisco
_eDermatología Médico Quirúrgica y Venereología
245 0 0 _aIncidencia a los 2 años de psoriasis, uveítis y enfermedad inflamatoria intestinal en la cohorte de pacientes con espondiloartritis del estudio AQUILES.
_h[artículo]
260 _bReumatología clínica,
_c2016
300 _a12(1):22-6.
500 _aFormato Vancouver: García Vicuña R, Zarco P, González CM, Vanaclocha F, Marín Jiménez I, Cea Calvo L. Incidencia a los 2 años de psoriasis, uveítis y enfermedad inflamatoria intestinal en la cohorte de pacientes con espondiloartritis del estudio AQUILES. Reumatol Clin. 2016 Jan-Feb;12(1):22-6.
501 _aPMID: 25683367
504 _aContiene 27 referencias
520 _aObjectives: To describe the 2-year incidence of new extra-articular manifestations (uveitis, psoriasis, inflammatory bowel disease) in a cohort of patients with spondyloarthritis included in the AQUILES study. Patients: Over a period of 2 years, 513 patients with spondyloarthritis (62.5% males, mean age 48 years) diagnosed with ankylosing spondylitis (AS) (55.6%), psoriatic arthritis (25.3%), undifferentiated spondyloarthritis (16.2%), enteropathic arthritis (2.5%), and other diseases (0.4%) were followed. New diagnoses were based on reports of the corresponding specialists (ophthalmologists, dermatologists, gastroenterologists). Results: During the 2-year follow-up, 22 new diagnoses of the extra-articular manifestations were established, with a cumulative incidence of 4.3% (95% confidence interval 2.4-6.1) and an incidence rate of 17 cases per 10,000 patient-year. Uveitis was the most frequent diagnosis (cumulative incidence 3.1%), predominantly in patients with AS. In the multivariate analysis, the diagnosis of AS was the only predictive variable associated to the development of new extra-articular disease. Conclusions: In patients with spondyloarthritis, the 2-year global incidence of uveitis, psoriasis and inflammatory bowel disease (IMID) was 4.3%, particularly due to new diagnoses of uveitis in patients with AS.
710 _9145
_aServicio de Dermatología Médico-Quirúrgica y Venereología
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc17466.pdf
_ySolicitar documento
942 _2ddc
_cART
_n0